Omega Diagnostics, a medical testing company, has reported greater interim losses despite an increase in revenues.

Omega Diagnostics, a medical testing company, has reported greater interim losses despite an increase in revenues.
INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 SEPTEMBER 2021
Omega (AIM: ODX), the specialist medical diagnostics company focused on industry-leading Global Health (CD4 and COVID-19) and Health and Nutrition products, announces it will release its interim results for the
Omega (AIM: ODX), the specialist medical diagnostics company focused on industry-leading Global Health (CD4 and COVID-19) and Health and Nutrition products, notes the UK Health Security Agency’s Medical Devices (Coronavirus
Agreement for Omega’s Market Leading, UK Manufactured VISITECT ® COVID-19 Antigen LFT
Omega (AIM: ODX), the medical diagnostics company focused on Global Health (CD4 and COVID-19) and Health and Nutrition, will hold its Annual General Meeting (‘AGM’) today at 11am at Omega
All supporting data and documentation now submitted to Omega’s European Notified Body
Omega (AIM: ODX), the medical diagnostics company focused on Global Health (CD4 and COVID-19) and Health and Nutrition, announces that the Notice of Annual General Meeting (‘AGM’).
AbC-19TM test to monitor vaccine responses to variants of concern AbC-19TM able to detect antibody response to different vaccines as well as natural infection
Business secretary Kwasi Kwarteng urged workers not to delete the test and trace app from their phones to avoid being pinged
To contain the pandemic, governments around the globe imposed rapid border restrictions in an effort to limit the spread of the disease. Travel stocks were forced to surrender.